Krishna Polu
Steering Committee Member, Venture Philanthropy at Lupus Research Alliance
San Francisco Bay Area
Overview
Work Experience
Steering Committee Member, Venture Philanthropy
2024 - Current
The Alliance for Lupus Research is an American voluntary health organization based in New York City
Chief Executive Officer
2023
Director Board of Directors
2023 - 2023
Sardona Therapeutics is a Scaling New Peaks in Cancer Therapy.
Director Board of Directors
2022 - 2023
Bicara Therapeutics develops dual-action cancer therapies, combining targeted treatments with tumor modulators for enhanced impact.
Raised $313,000,000.00 from F-Prime Capital, Janus Henderson Investors, PremjiInvest, Piper Heartland Healthcare Capital, Bioqube Ventures, Omega Funds, The Rise Fund, Braidwell, RA Capital Management and Eight Roads Ventures.
Principal
2020 - 2023
Director Board of Directors
2020 - 2022
Successful De-SPAC combo with New Amsterdam Pharma (NASDAQ:NAMS)
EVP of R&D and Chief Medical Officer
2018 - 2021
Equillium is a biotechnology company that develops products for autoimmune and inflammatory disorders with an unmet medical need.
Raised $85,000,000.00 from Decheng Capital.
Interim CEO
2018 - 2018
Scout Bio, Inc., a newly-formed development-stage biotechnology company focused on the discovery and development of vector-delivered protein and monoclonal antibody therapeutics for animal health. https://www.scoutbio.co/
Scout Bi is a biotechnology company that specializes in veterinary, animal health, and gene therapy.
Raised $62,290,416.00 from OrbiMed, Digitalis Ventures, Adage Capital Management, Frazier Healthcare Partners, Greenspring Associates, Correlation Ventures, RiverVest, Frazier Healthcare Partners, Companion Fund and Adage Capital Management.
Entrepreneur In Residence
2017 - 2018
CEO and Founder of Expedition Therapeutics, a Frazier Healthcare search company focused on identifying and in-licensing assets in the kidney, metabolic, and inflammatory therapeutic areas.
Frazier Healthcare Partners is a healthcare investment firm for pharmaceuticals, healthcare services, & medical products.
Chief Medical Officer
2015 - 2016
Acquired by Horizon Pharmaceuticals.